Vitamin D and Its Synthetic Analogs

Area of Science:

• Biochemistry
• Molecular Biology
• Endocrinology

Background:

• Vitamin D3 supplementation is vital for preventing bone disorders, muscle weakness, autoimmune diseases, and potentially cancer.
• Vitamin D3's active metabolite, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), acts as a potent agonist for the vitamin D receptor (VDR).
• Vitamin D influences chromatin structure and gene regulation across thousands of genomic loci, impacting the epigenome and transcriptome.

Purpose of the Study:

• To review significant vitamin D analogs developed over the past decade.
• To provide molecular insights into VDR-ligand interactions based on recent structural data.
• To enhance understanding of vitamin D's mechanism of action in target tissues.

Main Methods:

• Analysis of structural data from nearly 150 crystal structures of the VDR ligand-binding domain.
• Review of chemical modifications of 1,25(OH)2D3 and nonsteroidal VDR modulators.
• Synthesis and evaluation of novel vitamin D analogs and antagonists.

Main Results:

• Numerous potent VDR agonists and some antagonists have been developed through modifications of 1,25(OH)2D3 and nonsteroidal mimics.
• Detailed molecular understanding of VDR-ligand interactions is achievable through crystallographic data.
• Recent structural information provides new insights into VDR protein function.

Conclusions:

• The development of diverse vitamin D analogs offers therapeutic potential for various conditions.
• Structural biology provides a powerful tool for understanding and designing VDR-targeting drugs.
• Continued research into VDR modulation is essential for advancing treatments related to vitamin D deficiency and VDR-mediated diseases.